Transmission-blocking interventions eliminate malaria from laboratory populations

Nature Communications

Volumn 4, Issue , 2013, Pages

  Blagborough, A M ^a   Churcher, T S ^a   Upton, L M ^a   Ghani, A C ^a   Gething, P W ^b   Sinden, R E ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE;

COMMUNITY STRUCTURE; DISEASE TRANSMISSION; DISEASE VECTOR; ENDEMIC SPECIES; HOST-PARASITE INTERACTION; LABORATORY METHOD; MALARIA; MOSQUITO; PARASITIC DISEASE; REPRODUCTION; VERTEBRATE;

ANOPHELES STEPHENSI; ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG EFFICACY; FEMALE; HOST; MALARIA; MOUSE; NONHUMAN; OOCYST; PARASITEMIA; PLASMODIUM BERGHEI; PREVALENCE; REPRODUCTION;

ANIMALS; ANIMALS, LABORATORY; ANOPHELES; ANTIMALARIALS; ATOVAQUONE; FEEDING BEHAVIOR; FEMALE; GEOGRAPHY; MALARIA; MICE; MODELS, BIOLOGICAL; PLASMODIUM BERGHEI;

ANOPHELES STEPHENSI; HEXAPODA; PLASMODIUM BERGHEI; VERTEBRATA;

EID: 84878575632     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2840     Document Type: Article

References (31)

1. WHO.WHO GlobalMalaria Program: World Malaria Report 2012 (WHO, 2012)
2. Sinden, R.E. A biologist's perspective on malaria vaccine development. Hum. Vaccin. 6, 3-11 (2010)
3. Alavi, Y. et al. The dynamics of interactions between Plasmodium and the mosquito: a study of the infectivity of Plasmodium berghei and Plasmodium gallinaceum, and their transmission by Anopheles stephensi, Anopheles gambiae and Aedes aegypti. Int. J. Parasitol. 33, 933-943 (2003) (Pubitemid 37297460)
4. Rosenberg, R. Malaria: some considerations regarding parasite productivity. Trends Paras. 24, 487-491 (2008)
5. Smith, D.L., Ellis McKenzie, F., Snow, R.W. & Hay, S.I. Revisiting the basic reproductive number for malaria and its implications for malaria control. PLoS Biol. 5, 531-541 (2007)
6. Carter, R. Spatial simulation of malaria transmission and its control by malaria transmission blocking vaccination. Int. Jour. Parasito. 32, 1617-1624 (2002) (Pubitemid 35336003)
7. Stowers, A. & Carter, R. Current developments in malaria transmissionblocking vaccines. Expert. Opin. Biol. Ther. 1, 619-628 (2001) (Pubitemid 33769074)
8. Sinden, R.E. et al. On the design and interpretation of laboratory assays measuring mosquito transmission of Plasmodium. Parasitology 28, 457-465 (2012)
9. Medley, G.F. et al. Heterogeneity in patterns of malarial oocyst infections in the mosquito vector. Parasitology 106, 441-449 (1993) (Pubitemid 23169804)
10. Churcher, T.S. et al. Measuring the blockade of malaria transmission - an analysis of the standard membrane feeding assay. Int. J. Para. 42, 1037-1044 (2012)
11. The malERA Consultative Group on Vaccines. A research agenda for malaria eradication: vaccines. PLoS Med. 8, e1000398 (2011)
12. Saul, A. efficacy model for mosquito stage transmission blocking vaccines for malaria. Parasitology 135, 1497-1506 (2008)
13. Fowler, R.E., Billingsley, P.F., Pudney, M. & Sinden, R.E. Inhibitory action of the anti-malarial compound atovaquone (566C80) against Plasmodium berghei ANKA in the mosquito, Anopheles stephensi. Parasitology 108, 383-388 (1994) (Pubitemid 24159560)
14. Blagborough, A.M. et al. in Malaria Methods and Protocols. Chapter 7.6. (ed. Menard, R.) Assessing transmission-blocking in Plasmodium spp. 577-600 (Humana, 2012)
15. Gething, P.W. et al. Climate change and the global malaria recession. Nature 465, 342-345 (2010)
16. Becker, N. A general chain binomial model for infectious diseases. Biometrics 37, 251-258 (1981)
17. van der Kolk, M. et al. Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data. Parasitology 130, 13-22 (2005)
18. Wu, Y. et al. Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. PLoS One 3, e2636 (2008)
19. Cheru, L. et al. The IC(50) of anti-Pfs25 antibody in membrane-feeding assay varies among species. Vaccine 17, 4423-4429 (2010)
20. Goodman, A.L. et al. A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity. PLoS One 6, e29428 (2011)
21. Outchkourov, N. et al. Epitope analysis of the malaria surface antigen pfs48/45 identifies a subdomain that elicits transmission blocking antibodies. J Biol. Chem. 8, 17148-17156 (2007) (Pubitemid 47093201)
22. Outchkourov, N. et al. Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice. Proc. Natl Acad. Sci. USA 18, 4301-4305 (2008) (Pubitemid 351754375)
23. Williamson, K.C., Keister, D.B., Muratova, O. & Kaslow, D.C. Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes. Mol. Biochem. Parasitol. 75, 33-42 (1995) (Pubitemid 26025504)
24. v Pelt-Koops, J.C. et al. The spiroindolone drug candidate NITD609 potently inhibits gametocytogenesis and blocks Plasmodium falciparum transmission to Anopheles mosquito vector. Antimicrob. Agents Chemother. 56, 3522-3528 (2012)
25. Saul, A. Minimal efficacy requirements for malarial vaccines to significantly lower transmission in epidemic of seasonal malaria. Acta Tropica. 52, 283-296 (1993) (Pubitemid 23043718)
26. Gething, P.W. et al. A new world malaria map: Plasmodium falciparum endemicity in 2010. Malar. J. 20, 378 (2011)
27. Smith, D. L. et al. The entomological inoculation rate and Plasmodium falciparum infection in African children. Nature 438, 492-495 (2005) (Pubitemid 41742019)
28. Smith, T.A., Chitnis, N., Brie?t, O.J.T. & Tanner, M. Uses of mosquito-stage transmission-blocking vaccines against Plasmodium falciparum. Trends Paras. 27, 190-196 (2011)
29. Sinden, R.E. Molecular interactions between Plasmodium and its insect vectors. Cell Microbiol. 4, 713-724 (2002) (Pubitemid 35378711)
30. Macdonald, G. Epidemiological basis of malaria control. Bull. World Health Organ. 15, 613-626 (1956)
31. Dietz, K. The estimation of the basic reproduction number for infectious diseases. Stat. Methods Med. Res. 2, 23-41 (1993).